Stromal Vascular Fraction and Amniotic Epithelial Cells: Preclinical and Clinical Relevance in Musculoskeletal Regenerative Medicine
Musculoskeletal regenerative medicine is mainly based on the use of cell therapy to heal damaged tissues such as bone, cartilage, and tendons. Throughout the years, different cell types have been employed for the treatment of musculoskeletal diseases, in particular, mesenchymal stem cells (MSCs) der...
Main Authors: | Francesca Veronesi, Melania Maglio, Deyanira Contartese, Lucia Martini, Aurelio Muttini, Milena Fini |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2021/6632052 |
Similar Items
-
New and Emerging Strategies in Platelet-Rich Plasma Application in Musculoskeletal Regenerative Procedures: General Overview on Still Open Questions and Outlook
by: Francesca Salamanna, et al.
Published: (2015-01-01) -
Sex Specific Determinants in Osteoarthritis: A Systematic Review of Preclinical Studies
by: Deyanira Contartese, et al.
Published: (2020-05-01) -
Nano-Based Biomaterials as Drug Delivery Systems against Osteoporosis: A Systematic Review of Preclinical and Clinical Evidence
by: Francesca Salamanna, et al.
Published: (2021-02-01) -
Amniotic membrane‐mesenchymal stromal cells secreted factors and extracellular vesicle‐miRNAs: Anti‐inflammatory and regenerative features for musculoskeletal tissues
by: Enrico Ragni, et al.
Published: (2021-07-01) -
Progesterone prevents epithelial-mesenchymal transition of ovine amniotic epithelial cells and enhances their immunomodulatory properties
by: Angelo Canciello, et al.
Published: (2017-06-01)